AnaptysBio Inc banner

AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 56.73 USD 2.29% Market Closed
Market Cap: $1.6B

Wall Street
Price Targets

ANAB Price Targets Summary
AnaptysBio Inc

Wall Street analysts forecast ANAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANAB is 79.82 USD with a low forecast of 50.5 USD and a high forecast of 147 USD.

Lowest
Price Target
50.5 USD
11% Downside
Average
Price Target
79.82 USD
41% Upside
Highest
Price Target
147 USD
159% Upside
AnaptysBio Inc Competitors:
Price Targets
SHLS
Shoals Technologies Group Inc
44% Upside
QXO
SilverSun Technologies Inc
72% Upside

Revenue
Forecast

28% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
28% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

For the last 11 years the compound annual growth rate for AnaptysBio Inc's revenue is 28%. The projected CAGR for the next 3 years is 4%.

Operating Income
Forecast

23% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
23% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 11 years the compound annual growth rate for AnaptysBio Inc's operating income is 23%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANAB's stock price target?
Price Target
79.82 USD

According to Wall Street analysts, the average 1-year price target for ANAB is 79.82 USD with a low forecast of 50.5 USD and a high forecast of 147 USD.

What is AnaptysBio Inc's Revenue forecast?
Projected CAGR
4%

For the last 11 years the compound annual growth rate for AnaptysBio Inc's revenue is 28%. The projected CAGR for the next 3 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett